Login to Your Account



Immunomic's LAMP Lights Path Toward DNA Vaccines

By Marie Powers
Staff Writer

Thursday, March 7, 2013
Privately held Immunomic Therapeutics Inc. (ITI) worked quietly for five years to advance its LAMP-vax technology, based on lysosomal associated membrane protein (LAMP), a ubiquitous glycoprotein found on 80 percent of the surface area of lysosomal membranes.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription